Applied Therapeutics has filed a notice of an exempt offering of securities to raise $30,000,002.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Applied Therapeutics is raising $30,000,002.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shoshana Shendelman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Applied Therapeutics
Applied Therapeutics is a clinical-stage biopharmaceutical company that uses our novel drug-development approach to create transformative, life-changing treatments for the patients who desperately need them. Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology. By applying the right science and the right development strategies, Applied Therapeutics aims to rapidly advance new treatments for patients with high unmet medical need.
To learn more about Applied Therapeutics, visit http://www.appliedtherapeutics.com/
Contact:
Shoshana Shendelman, Chief Executive Officer
212-220-9319
https://www.linkedin.com/in/shoshana-shendelman-phd-8756926/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.